Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Inside Azenta’s partnership with the PRECEDE Foundation driving breakthroughs in early pancreatic cancer diagnostics Discover how Azenta Life Sciences and the PRECEDE Foundation are building a global biobanking network to transform early pancreatic cancer detection. bySoujanya RaviNovember 5, 2025